<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The polycomb group (PcG) protein BMI1 plays a critical role in regulating self renewal capacity of both <z:mpath ids='MPATH_458'>normal</z:mpath> and leukemic stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>BMI1 is frequently overexpressed in several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, which is associated with poor prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>However, there are few researches on BMI1 in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we reported that overexpression of BMI1 protein was detected in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, and inversely correlated with the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of CD34+ cells </plain></SENT>
<SENT sid="4" pm="."><plain>In vitro overexpression of BMI1 facilitated proliferation and inhibited <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-L cells </plain></SENT>
<SENT sid="5" pm="."><plain>The overexpression of BMI1 could downregulate <z:mpath ids='MPATH_3'>apoptosis</z:mpath> sensitivity to cytotoxic agents in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-L cells; on the contrary, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-L cells could be rendered <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-sensitive by BMI1 knockdown </plain></SENT>
<SENT sid="6" pm="."><plain>Overexpression of BMI1 antagonised <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by downregulating several <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-related proteins, such as p16(INK4a), phospho-p53 (Ser46) and caspase 3/9 </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, overexpression of BMI1 was correlated with an elevated IPSS score and a shorter survival </plain></SENT>
<SENT sid="8" pm="."><plain>Collectively, overexpression of BMI1 induces resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and contributes to adverse prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>BMI1 could serve as a therapeutic target for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>